NASDAQ:PETQPetIQ Stock Price, Forecast & News

PetIQ's stock was trading at $22.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PETQ shares have increased by 30.1% and is now trading at $29.38.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for PetIQ.

PetIQ is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for PetIQ.

PetIQ Inc (NASDAQ:PETQ) posted its quarterly earnings data on Tuesday, March, 10th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.09 by $0.18. The business had revenue of $154.34 million for the quarter, compared to analysts' expectations of $134.80 million. PetIQ had a negative net margin of 2.63% and a positive return on equity of 8.72%.
View PetIQ's earnings history.

PetIQ issued an update on its third quarter 2020 After-Hours earnings guidance on Thursday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $160-170 million, compared to the consensus revenue estimate of $205.77 million.

4 brokerages have issued 12 month price objectives for PetIQ's shares. Their forecasts range from $44.00 to $50.00. On average, they expect PetIQ's share price to reach $45.75 in the next year. This suggests a possible upside of 55.7% from the stock's current price.
View analysts' price targets for PetIQ.

News headlines about PETQ stock have been trending extremely negative this week, according to InfoTrie. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. PetIQ earned a coverage optimism score of -4.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next several days.
View the latest news about PetIQ.

PetIQ saw a increase in short interest in May. As of May 29th, there was short interest totaling 4,990,000 shares, an increase of 51.7% from the May 14th total of 3,290,000 shares. Based on an average daily volume of 456,500 shares, the short-interest ratio is presently 10.9 days.
View PetIQ's Short Interest.

Some companies that are related to PetIQ include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Trxade Group (TRXD), MultiCell Technologies (MEDS) and biOasis Technologies (BIOAF).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), Crispr Therapeutics (CRSP), CVS Health (CVS), Oracle (ORCL) and Canopy Growth (CGC).

(PETQ) raised $86 million in an IPO on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

PetIQ's stock is owned by many different retail and institutional investors. Top institutional investors include Wasatch Advisors Inc. (5.72%), Ensign Peak Advisors Inc (2.90%), Riverbridge Partners LLC (2.36%), Peregrine Capital Management LLC (2.16%), Russell Investments Group Ltd. (1.27%) and Goldman Sachs Group Inc. (1.19%). Company insiders that own PetIQ stock include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen, Robert Michael Herrman, Susan Sholtis and Will Santana.
View institutional ownership trends for PetIQ.

PETQ stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Goldman Sachs Group Inc., Peregrine Capital Management LLC, Aperture Investors LLC, WINTON GROUP Ltd, PNC Financial Services Group Inc., AMI Asset Management Corp, and Principal Financial Group Inc..
View insider buying and selling activity for PetIQ.

PETQ stock was bought by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Cadence Capital Management LLC, Wasatch Advisors Inc., TRH Financial LLC, Ensign Peak Advisors Inc, Bank of Montreal Can, UBS Group AG, and Skandinaviska Enskilda Banken AB publ . Company insiders that have bought PetIQ stock in the last two years include James Nathan Clarke, John Newland, and Robert Michael Herrman.
View insider buying and selling activity for PetIQ.

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETQ stock can currently be purchased for approximately $29.38.

PetIQ has a market capitalization of $833.80 million and generates $709.43 million in revenue each year. The company earns $-11,450,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. PetIQ employs 1,866 workers across the globe.

The official website for PetIQ is www.petiq.com.

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]